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Abstract 
Ethnopharmacological relevance: Traditional Chinese Medicine (TCM) has become 
the focus of research for the treatment of chronic pelvic inflammatory disease (CPID) 
based on unique medical theory system. Man-Pen-Fang (MPF), a Chinese herbal 
compound, which is composed of Thlaspi arvense L. (Cruciferae), Gleditsia sinensis 
Lam. (Leguminosae), Smilax china L. (Liliaceae), Euonymus alatus (Thunb.) Sieb. 
(Celastraceae) and Vaccaria segetalis (Neck.) (Caryophyllaceae) MPF has been used 
for the treatment of CPID and exerted significant clinical curative effects. However, 
the corresponding active principles and anti-inflammatory mechanism of MPF are still 
unknown. 
Aim of the study: The objective of present study is to evaluate the effect of MPF on 
CPID in the chronic pelvic inflammation (CPI) rat model and elucidate its possible 
anti-inflammatory mechanism. 
Materials and Methods: The CPI in rats was induced by administration with E. coli, 
Staphylococcus aureus and Beta-hemolytic streptococcus. MPF (8.112 g/(kg.d) (20 
times of adult dosage), 4.056 g/(kg.d) (10 times of adult dosage) and 2.028 g/(kg.d) (5 
times of adult dosage)) and Jingangteng Capsule 2 g/(kg.d) (20 times of adult dosage) 
were administered orally for 20 days. The serum levels of five 
inflammation-associated cytokines (IL-2, IL-6, IL-10, TNF-α and TGF-β1) were 
determined by enzyme-linked immunoassay, and the mRNA expression levels of 
TGF-β1, P53, Fas, FasL and MMP-2 in the uterus tissue were measured by 
quantitative RT-PCR. Furthermore, the expression of NF-κB p65 in uterus and ovary 
tissues was detected by immunohistochemistry assay and the pathological changes 
induced in the uterus and ovary tissues were observed by histology. 
Results: MPF caused a reduction in serum levels of IL-2, IL-6, IL-10, TNF-α and 
TGF-β1. The expression of P53 mRNA, Fas/FasL mRNA and MMP-2 mRNA in the 
uterus tissue was significantly elevated after treating with MPF, in contrast the 
expression of TGF-β1 mRNA was decreased. Furthermore, the expression of NF-κB 
p65 in uterus and ovary tissue was inhibited after treating with MPF. 
Conclusions: These results taken together suggest that MPF has a significant 
anti-CPID effect, probably due to inhibition of the inflammation reaction by the 
promotion, and the induction of the apoptosis of inflammatory cells and 
downregulation of the serum levels of inflammation cytokines.  
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1. Introduction 
Pelvic inflammatory disease (PID) is an infection and inflammation of the uterus, 
ovaries, and other female reproductive organs and is one of the most common 
infections in non-pregnant women of reproductive age and remains an important 
public health problem (Loucks, 1983; Snaith, 1959). It can lead to long-term sequelae, 
such as infertility, ectopic pregnancy, pelvic pain, abscesses, and other serious 
problems (Cassell et al., 1997). These problems are called sequelae of pelvic 
inflammatory disease (SPID) or chronic pelvic inflammatory disease (CPID), which 
seriously influence the health of women and the quality of life and increases the 
economic burden of family and society (Barrett and Taylor, 2005; Gradison, 2012). 
The sexually transmitted organisms, Neisseria gonorrhoeae and Chlamydia 
trachomatis are present in many cases and microorganisms comprising the 
endogenous vaginal and cervical flora are frequently associated with PID. These 
include anaerobic and facultative bacteria, similar to those associated with bacterial 
vaginosis (Burnakis and Hildebrandt, 1986; Duarte et al., 2015). Some women have 
no symptoms while others have pain in the lower abdomen, fever, foul smelling 
vaginal discharge, irregular bleeding, and pain during intercourse or urination 
(Haggerty et al., 2005). Early treatment is important as waiting too long increases the 
risk of infertility. 
There are many disadvantages of antibiotics and surgical treatment for CPID, hence 
Traditional Chinese Medicine (TCM) has become the focus of research for the 
treatment of CPID. There is no definition of CPID in TCM. And in the theory of TCM, 
CPID is considered to be caused by cold and dampness damage to the uterus and 
uterine collateral leading to Qi obstruction, stagnation of blood stasis, recurrent and 
refractory lingering (Chen, 2012; Liu et al., 2014; Bu et al., 2015). The main 
pathogenesis of CPID is stagnation of blood stasis. Thus, promoting and dredging the 
channel circulation and removing stasis are principles of the treatment for CPID (Liu 
et al., 2014). 
A Chinese herbal compound, Man-Pen-Fang (MPF), which is composed of Thlaspi 
arvense L. (Cruciferae), Gleditsia sinensis Lam. (Leguminosae), Smilax china L. 
(Liliaceae), Euonymus alatus (Thunb.) Sieb. (Celastraceae) and Vaccaria segetalis 
(Neck.) (Caryophyllaceae), as shown in Table 1 is effective in dispersing blood stasis 
and dredging collaterals. In this Chinese medicine formula, Thlaspi arvense L. is 
recorded in Shen Nong’s Herbal Classic and is reported to clear heat, is an 
antitoxicant, activates blood, and resolves stasis. Compendium of Materia Medica 
indicates that Gleditsia sinensis Lam. has effect on removing toxicity for 
detumescence (Kim et al., 2015; Li et al., 2016). Smilax China L. is good at dispelling 
wind-damp, reducing swelling and activating blood circulation to dissipate blood 
stasis (Lee et al., 2001; Shah et al., 1962). Euonymus alatus (Thunb.) Sieb. activates 
blood to promote menstruation and Vaccaria segetalis (Neck.) has analgesic and 
anti-inflammatory effects. All these drugs have a role in activating blood circulation 
to dissipate blood stasis, clearing heat as an antitoxicant, reducing swelling and 
analgesia. 
 
Table 1 The composition of Man-Pen-Fang (MPF) 
Scientific name Chinese name Weight (g) % 
Thlaspi arvense L. (Cruciferae) Baijiangcao 30 20 
Gleditsia sinensis Lam. (Leguminosae) Zaojiaoci 30 20 
Smilax china L. (Liliaceae) Baqia 30 20 
Euonymus alatus (Thunb.) Sieb. (Celastraceae) Guijianyu 30 20 
Vaccaria segetalis (Neck.) (Caryophyllaceae) Wangbuliuxing 30 20 
Total amount  150 100 
 MPF has a history of clinical use for the treatment of CPID more than 20 years and 
has a significant curative effect (Ye, 2009). Herein, CPI model in rats was established 
to evaluate the anti-inflammatory effect of MPF on CPID. In order to explore the 
possible mechanism of MPF, the serum levels of five inflammatory cytokines (IL-2, 
IL-6, IL-10, TNF-α, and TGF-β1) were measured by Elisa assay followed by the 
measurement of mRNA expression levels of TGF-β1, P53, Fas, FasL, and MMP-2 in 
uterus tissue by quantitative RT-PCR. Furthermore, the expression of NF-κB p65 in 
uterus and ovary tissues was measured by immunohistochemistry assay and finally 
the tissues were examined histologically by staining with haematoxylin and eosin to 
ascertain the effect of MPF on CPID. 
 
2. Materials and Methods 
2.1 Bacterial strains and Animals 
E. coli (ATCC25922) and Staphylococcus aureus (ATCC29213) were obtained from 
bacteriological laboratory of Seventh People’s Hospital of Shanghai University of 
Traditional Chinese Medicine. Beta-hemolytic streptococcus (CMCC32210) was 
purchased from Beina Chuanglian biotechnology research institute. The three 
bacterial strains were cultured by the conventional bacterial cultivation method. 
Female Wistar rats, 6-8 weeks old were obtained from animal laboratory of Seventh 
People’s Hospital of Shanghai University of Traditional Chinese Medicine and were 
kept at room temperature. 
2.2 Preparation of Man-Pen-Fang 
The crude drugs of Man-Pen-Fang were purchased from Shanghai Kangqiao Chinese 
herbal pieces co., LTD. All the herbs were prepared in proportion by soaking in 8 
times the weights of pure water and were extracted twice by refluxing for 1 h. The 
filtrate was merged, concentrated under vacuum and the moisture was removed by 
placing the samples in an oven at 50 ℃. The extract was then used for the following 
experiments.  
2.3 HPLC/ESI-MS and Fingerprint Analysis 
An Agilent 1100 HPLC system, equipped with a quaternary pump, an autosampler, a 
degasser, an automatic thermostatic column compartment , a DAD and an LC/MSD 
Trap XCT ESI mass spectrometer (Agilent Technologies, MA, USA), was used for the 
analysis of the herb. The separation was performed on a GS-120-5-C18-BIO 
chromatographic column (5 m, 250  4.6 mm i.d.) with the column temperature set 
at 35℃. A linear gradient elution of A (0.1% formic acid water) and B (acetonitrile) 
was used with the gradient procedure as follows: 0 min, B 5%, to 60 min B 40% (v/v). 
The flow rate was 1.0 mL/min and the injection volume was 10 L. DAD was on and 
the target wavelength was simultaneously set at 210 nm. The split ratio to the mass 
spectrometer was 1:3. The acquisition parameters for negative ion mode were: 
collision gas, ultra high-purity helium (He), nebulizer gas (N2), 35 psi, drying gas (N2), 
10 L/min, drying temperature, 350°C, HV, 3500 V, mass scan range, m/z 100-2200, 
target mass, 500 m/z, compound stability, 100%, trap drive level, 100%. All the data 
were analyzed by Chemstation software. 
2.4 The establishment of CPID model in rats and Animal treatment 
The oestrus of female Wistar rats was identified by vaginal smear for continuous 3 
cycles. Only those with regular cycles were allowed to continue the next experiments. 
Suitable female Wistar rats were anesthetized with an intraperitoneal injection of 
10 % chloral hydrate and the endometrial tissue was damaged with a syringe, 
followed by administration of a mixture of E. coli, Staphylococcus aureus and 
Beta-hemolytic streptococcus of 9×105 IFUs in 0.15 mL distilled water to the uterus 
on the right hand side (Tuffrey et al., 1992; Chen Ying, 2008;). E. coli, 
Staphylococcus aureus and Beta-hemolytic streptococcus were in a ratio of 2:1:1.  
Seven days after infection, successfully infected rats were randomly divided into 5 
groups (n=10) as following: the model group, positive group, and high-dose, 
mid-dose and low-dose MPF groups (MPF-H, MPF-M and MPF-L). 10 female Wistar 
rats did not receive any treatment and served as the control group. The drug was 
intragastrically administrated to the rats for 20 days, and the distilled water was used 
as control. The rats in the control group and the model group received distilled water 
in the same volume; in the positive group, Jingangteng Capsule 2 g/(kg.d) (20 times 
of adult dosage) was dissolved in distilled water; in the MPF-H, MPF-M and MPF-L 
groups, MPF was dissolved at 8.112 g/(kg.d) (20 times of adult dosage), 4.056 g/(kg.d) 
(10 times of adult dosage) and 2.028 g/(kg.d) (5 times of adult dosage), respectively. 
2.5 Elisa assay 
The rats were anesthetized with an intraperitoneal injection of 1.5 % pentobarbital 
sodium (40 mg/kg), blood was collected by abdominal aortic method followed by 
centrifugation at 3000 rpm for 10 min. The plasma was analysed for interleukin-2 
(IL-2), interleukin-6 (IL-6), interleukin-10 (IL-10), tumor necrosis factor alpha 
(TNF-α) and transforming growth factor beta 1 (TGF-β1) level by using a 
commercially available enzyme-linked immunosorbent assay (ELISA). ALL the Elisa 
kits were purchased from Shanghai Maiye biological technology co., Ltd. From each 
plasma sample, 50 μL was directly transferred to the microtest strip wells of the 
ELISA plate and then assayed according to the manufacturer's instructions. 
Absorbance was measured at 450 nm in a microtest plate spectrophotometer. 
2.6 RNA extraction, reverse transcription and quantitative RT-PCR 
The rats were anesthetized with an intraperitoneal injection of 1.5 % pentobarbital 
sodium (40 mg/kg). The uterus tissues were chosen for RNA extraction. Total RNA 
was extracted by TransZol Up reagent (TransGen Biotech, China) and 2 μg of total 
RNA was reversely transcribed to cDNA with oligo (dT) primer using the TransScript 
First-Strand cDNA Synthesis Supermix Reagent Kit (TransGen Biotech, China). 
Quantitative RT-PCR was performed using a TransStart Top Green qPCR SuperMix 
Reagent Kit (TransGen Biotech, China) protocol on lightcycler96 (Roche, 
Switzerland) thermal cycler according to manufacturer’s instruction. GAPDH mRNA 
levels were used for normalization. The primers sequences (sense/antisense) were 
provided by Sangon Biotech (Shanghai) Co., Ltd. and list in Table 2.  
2.7 Histology 
The uterus and ovary tissues were dehydrated and embedded in paraffin, and 4-7 μm 
sections were deparaffinized and stained sequentially with haematoxylin and eosin 
(H&E, BASO, China). Stained tissue sections on slides were analyzed under identical 
light microscope (D5100, NIKON, Japan) at × 400 magnifications. 
  
 
Table 2 Primers sequences used in this study 
Gene Sequences (5′-3′) 
GAPDH-forward GGTCGGTGTGAACGGATTTG 
GAPDH-reverse CGTTGAACTTGCCGTGGGTA 
FAS- forward TTGCTGTCAACCGTGTCAGC 
FAS- reverse CCACTTCTAAACCATGCCCT 
FASL- forward CACCAACCACAGCCTTAGAG 
FASL- reverse CCAGAGATCAAAGCAGTTCC 
MMP2- forward AAGCTCATCGCAGACTCCTGG 
MMP2- reverse CAGCCAGTCCGATTTGATGC 
P53- forward ACCAGCACAAGCTCCTCTC 
P53- reverse TCTTGGTCTTCGGGTAGCTG 
TGF- forward AAGGAGACGGAATACAGGGC 
TGF- reverse CAGGTGTTGAGCCCTTTCCA 
 
2.8 Immunohistochemistry 
The uterus and ovary tissues were treated for deparaffinization and hydration and then 
heated in EDTA (pH = 8.0) and incubated with 3 % hydrogen peroxide for 10 min for 
antigen retrieval. The reaction of NF-κB p65 rabbit monoclonal antibody (Abcam, 
USA) was allowed to take place for 1 h at room temperature, followed by incubation 
with goat anti-rabbit horseradish peroxidase-conjugated IgG (Shanghai Long Island 
Biotec.Co., Ltd., China). Slides were stained with DAB (Shanghai Long Island 
Biotec.Co., Ltd., China) and hematoxylin staining (BASO, China). 
Immunohistochemical signals were calculated with the positive staining cells and 
stained tissue ections on slides were analyzed under identical light microscope at × 
400 magnifications. 
2.9 Statistical analysis 
All experiments were performed in triplicate and the data was expressed as mean ± 
SD. Analysis of variance (ANOVA) and Student’s t-test were used to determine the 
statistically significant difference among different groups where appropriate. All 
statistical analyses were two-sided and performed using the Statistical Package for the 
Social Sciences software version 16.0 (SPSS, Inc., Chicago, IL, USA). Statistical 
significance was set at P <0.05.  
2.10 Statement  
The experiments were carried out in accordance with the guidelines issued by the 
Experimental Animal Ethical Committee of Seventh People’s Hospital of Shanghai 
University of Traditional Chinese Medicine (EAEC/SPH#46/2015).  
  
3. Results  
3.1 Identification of Compounds 
The aqueous extract of a mixture of five Chinese medicinal herbs was analysed by 
high-performance liquid chromatography coupled with electrospray mass 
spectrometry (HPLC/ESI-MS) in negative and positive-ion mode (Figure 1). Eight 
compounds 1 - 8 (Figure S1 - S8), with the retention time at 0.68 min, 4.54 min, 4.67 
min, 4.90 min, 5.14 min, 5.49 min, 7.27 min, and 3.95 min, were identified as 
hydroferulic acid (1), kaempferol-3-O-rutinoside (2), (-)-catechin (3), vaccarin (4), 
isoorientin (5), isovitexin (6), segetalin A (7), and (+)-usnic acid B (8), on the basis of 
the observation of the pseudomolecular ion peak at m/z 195.0491 [MH] (1), m/z 
593.1503 [M  H] (2), m/z 289.0699 [MH] (3), m/z 725.1927 [MH] (4), m/z 
447.0920 [MH] (5), m/z 431.0970 [MH] (6), m/z 608.3200 [MH] (7), m/z 
367.1506 [MNa]+ (8), in HPLC/ESI-MS chromatogram, in accordance with the 
molecular weights of eight compounds (hydroferulic acid, kaempferol-3-O-rutinoside, 
(-)-catechin, vaccarin, isoorientin, isovitexin, segetalin A, and (+)-usnic acid B) . A total 
of 8 compounds were unambiguously identified by comparing the retention times and 
the MS data with the reference standards. 
 Figure 1 HPLC/ESI-MS chromatogram of the aqueous extract in negative and 
positive mode (a and b)  
 
3.2 Effects of MPF on the serum levels of IL-2, IL-6, IL-10, TNF-α and TGF-β1 of 
CPID in rats 
In order to investigate the effect of MPF on the regulation of immune system, the 
levels of pro-inflammatory cytokines (IL-6 and TNF-α) and anti-inflammatory 
cytokines (IL-2, IL-10, and TGF-β1) were analyzed in plasma samples by Elisa assay. 
The results are presented in Figure 2 and Table 3. The serum levels of IL-2, IL-6, 
IL-10, TNF-α, and TGF-β1 were significantly elevated in the CPID model group when 
compared with those in the control group (P<0.01). These serum levels decreased in 
the positive, MPF-H, MPF-M, and MPF-L groups compared with those in the model 
group. These serum levels in MPF-H group were lower than those in the positive 
group, and similar to those in control group. In the MPF-H, MPF-M, and MPF-L 
groups, the significant differences were dependent on the dose of MPF. The higher the 
dose of MPF, the more significant was the differences. 
 Figure 2 The serum levels of IL-2, IL-6, IL-10, TNF-α, and TGF-β1. The serum levels 
were determined by Elisa assay in the control, model, positive, MPF-H, MPF-M and 
MPF-L groups. The results represent means ± SD of three independent experiments 
(n=10). ##P < 0.01, control versus model, **P < 0.01, *P < 0.05, model versus positive, 
MPF-H, MPF-M and MPF-L. 
 
Table 3 The serum levels of IL-2, IL-6, IL-10, TNF-α, and TGF-β1 (pg/mL) 
Groups IL-2 IL-6 IL-10 TNF-α TGF-β1 
Control 864.73±106.30 35.96±5.24 91.65±9.41 832.45±94.64 78.40±7.60 
Model 1773.26±217.84## 274.78±35.95## 332.77±39.06## 1294.00±122.44## 192.43±30.47## 
Positive 1020.04±129.64** 50.96±7.21** 105.93±16.65** 900.76±192.14** 97.07±12.75** 
MPF-H 986.31±109.87** 43.52±5.74** 72.39±7.44** 800.90±143.41** 76.59±10.65** 
MPF-M 1139.47±117.80** 164.20±21.88** 137.53±22.93** 790.92±100.33** 93.97±12.78** 
MPF-L 1487.33±185.93** 278.26±49.47 180.29±27.54** 952.47±208.52* 118.97±20.43** 
Results represent means ± SD of three independent experiments (n=10). ##P < 0.01, 
control versus model, **P < 0.01, *P < 0.05, model versus positive, MPF-H, MPF-M, 
MPF-L. 
 
3.3 Effects of MPF on the expression of TGF-β1 mRNA, P53 mRNA, Fas/FasL 
mRNA and MMP-2 mRNA in uterus of CPID rats 
The relative mRNA levels of TGF-β1, P53, Fas/FasL, and MMP-2 in uterus were 
measured by quantitative RT-PCR to investigate the effect of MPF on the expression 
of apoptosis gene. The results are presented in Figure 3 and Table 4. The levels of 
TGF-β1 mRNA, P53 mRNA, Fas/FasL mRNA, and MMP-2 mRNA as expected were 
higher in the CPID model group than those in the control group (P<0.01 & P<0.05). 
The expressions of P53 mRNA, Fas/FasL mRNA, and MMP-2 mRNA were increased 
in the positive, MPF-H, MPF-M, MPF-L groups when compared with those in the 
model group. The expression of TGF-β1 mRNA was lower in the positive, MPF-H, 
MPF-M, MPF-L groups than the levels observed in the model group. The significant 
differences were more common in the MPF-H and MPF-M groups, and these 
differences were dose-dependent. 
 
 
Figure 3 The relative mRNA levels of TGF-β1, P53, Fas, FasL and MMP2. These 
relative mRNA levels were detected by quantitative RT-PCR in uterus tissues from the 
control, model, positive (Smilax china L. Capsule), MPF-H, MPF-M and MPF-L 
groups. The results represent means ± SD of three independent experiments (n=10). 
##P < 0.01, control versus model, **P < 0.01, *P < 0.05, model versus positive, MPF-H, 
MPF-M and MPF-L.  
 
 
 
 
 
 
Table 4 Relative mRNA levels of TGF-β1, P53, Fas, FasL, and MMP2 
Groups TGF-β1 P53 Fas FasL MMP2 
Control 1.00±0.099 1.00±0.07 1.00±0.14 1.00±0.06 1.00±0.06 
Model 3.14±0.14## 2.13±0.28## 1.49±0.25# 1.64±0.20## 1.81±0.25## 
Positive 2.084±0.304** 6.20±0.34** 1.84±0.20* 2.01±0.22* 2.34±0.30* 
MPF-H 0.97±0.91** 11.67±0.29** 3.26±0.32** 5.03±0.74** 6.83±0.88** 
MPF-M 2.47±0.06** 5.68±0.38** 2.48±0.30** 3.70±0.20** 2.63±0.19** 
MPF-L 2.62±0.45* 2.14±0.26 1.62±0.21 1.84±0.12 2.39±0.22* 
Results represent means ± SD of three independent experiments (n=10). ## P < 0.01, 
control versus model, **P < 0.01, *P < 0.05, model versus positive, MPF-H, MPF-M, 
MPF-L. 
 
3.4 Effects of MPF on the pathologic structures of uterus and ovary tissues of 
CPID rats 
The changes of pathology of uterus and ovary tissues were observed by histology 
staining with H&E to confirm the effect of MPF on CPID. Figure 4A represents the 
histological images observed in the uterus tissues stained with H&E. In the control 
group, the chamber walls were clear, the uterus gland structure was normal, and there 
was no hyperemia and edema. While in the model group, the lamina propria became 
thinner or disappeared, the chamber wall structures were disordered, many chronic 
inflammatory cells were observed, and hyperemia and edema was obvious in the 
endometrium. In the positive group, there was still some chronic inflammatory cells 
present, and the endometrium was partly in hyperemia and edema. In the MPF-H 
group, the mucosal epithelial cells were ranked neatly, the hyperemia and edema in 
endometrium was significantly decreased, and the uterine lesions were almost 
reversed to normal. In the MPF-M and MPF-L groups, the uterine lesions were 
reversed back to normal to a certain extent. Figure 4B represents the histological 
images of ovary tissues stained with H&E. In the control group, the structure of ovary 
was clear, and the granular cells had normal morphology. In the model group, the 
atretic follicle was damaged, granular cells were ranked in disorder and the structure 
was loose. In the positive, MPF-H, MPF-M, and MPF-L groups, the damage to the 
ovarian lesions was reversed to a certain extent. The structure of granular cells 
became close and the atretic follicle damage was reversed. 
3.5 Effects of MPF on the expression of NF-κB p65 in uterus and ovary tissues of 
CPID rats 
To verify the changes of the protein levels, the expression of NF-κB p65 in uterus and 
ovary tissues were measured by immunohistochemistry and the results were shown in 
Figure 5. The expression of NF-κB p65 in uterus and ovary tissues in the model 
group was significantly higher than that in the control group (P<0.01). An obvious 
reduction of NF-κB p65 level was observed in the positive, MPF-H, MPF-M, and 
MPF-L groups. In the MPF-H, MPF-M, and MPF-L groups, the differences observed 
were dose-dependent. 
 
Figure 4 Histological images of uterus and ovary tissues stained with H&E. A. 
Histological images of uterus tissues staining with H&E. B. Histological images of 
ovary tissues staining with H&E. a. Control group, b. Model group, c. Positive group, 
d. MPF-H group, e. MPF-M group, f. MPF-L group. (original magnification × 400) 
 
 
Figure 5 Expression of NF-κB p65 in uterus and ovary tissues A. Expression of 
NF-κB p65 in uterus. B. Expression of NF-κB p65 in ovary tissues. a. Control group, 
b. Model group, c. Positive group, d. MPF-H group, e. MPF-M group, f. MPF-L 
group. (original magnification × 400) Results represent means ± SD of three 
independent experiments (n=10). ##P < 0.01, control versus model, **P < 0.01, *P < 
0.05, model versus positive, MPF-H, MPF-M, MPF-L. 
 
 
4. Discussion  
The CPID refers to chronic inflammation of the female internal reproductive organs，
surrounding connective tissue and the pelvic peritoneum．This can be present due to 
untreated acute PID and it can manifest itself as a mild，moderate chronic pelvic 
inflammatory disease due to the patient’s constitution or mild infection．In China，the 
rate of incidence of PID is very high due to personal health and medical conditions， 
indifferent aseptic concepts in minor gynecologic and family planning surgeries. 
Since there are many disadvantages in the use of antibiotics and surgical treatments of 
CPID，the use of traditional Chinese medicine has become significant in the treatment 
of CPID.  
MPF, a Chinese medicine formula, was formulated in accordance with the principle 
and in combination of herbs according to the doctors’ individual experience. MPF is 
composed of Thlaspi arvense L., Gleditsia sinensis Lam., Smilax china L., Euonymus 
alatus (Thunb.) Sieb., and Vaccaria segetalis (Neck.). Modern pharmacological 
studies have found that Thlaspi arvense L. has anti-bacterial and antiviral properties. 
Gleditsia sinensis Lam. has anti-bacterial, anti-inflammatory and anti-tumorigenic 
properties (Li et al., 2007; Zhou et al., 2007; Li et al., 2016;). And Smilax china L. has 
anti- inflammatory, anti-hyperuricemic and nephroprotective effects (Khan et al., 
2009; Chen et al., 2011). Jingangteng is the root of Smilax china L., a traditional 
Chinese herb which can promote blood circulation by removing blood stasis. It is 
commercially available in capsules and has been available in the market for more than 
10 years, and has remarkable curative effects. Euonymus alatus (Thunb.) Sieb. is 
reported to prevent hyperglycemia and hyperlipidemia (Park et al., 2005). Whilst 
Vaccaria segetalis (Neck.) can alleviate pain and has anti-inflammatory properties 
(Wang et al., 2015). All these drugs have a role as anti-inflammatory agents and are 
good at activating blood circulation by dissipating blood stasis, clearing eliminating 
heat as antitoxicants, reducing swelling and analgesia.  
Evidences from clinical studies indicate that inflammation plays a critical role in the 
initiation and development of CPID (Zhou et al., 2007; Mitchell and Prabhu, 2013). 
And most researchers consider that inflammatory injury is the key pathological 
change in CPID. Persistent activation of inflammatory factors and effusion of 
inflammatory cells lead to inflammatory autoimmune injury and subsequently 
indirectly or directly influence the initiation, progression and prognosis of SPID. 
Persistent inflammation results in blood stasis, and in turn, blood stasis promotes 
inflammation (Liu et al., 2014). In our previous study, it was revealed that MPF had 
remarkable anti-inflammatory and analgesic activities and is a promising herbal 
preparation which can be applied in the treatment of CPID (Ye et al., 2016). In this 
study, CPID model in rats was established in order to evaluate the effect of MPF on 
CPID and investigate its anti-inflammatory mechanism.  
The changes of pathology of uterus and ovary tissues were observed by staining with 
H&E and it was confirmed that MPF had significant anti-inflammatory effect on 
CPID. It is known that the balance between pro- and anti-inflammatory cytokines is 
the key to maintain the body’s normal immune status (Chou et al., 2013). When the 
balance is disturbed, the body will be prone to inflammatory diseases (Christensen et 
al., 1998; Basic Kes et al., 2008). The regulation of pro- and anti-inflammatory 
cytokines in inflammatory response is a very complicated process and almost all the 
anti-inflammatory cytokines have part to play in the induction of inflammation except 
IL-1 (Dinarello, 1997). TNF-α and IL-6 which are well-known pro-inflammatory 
cytokines (Alexander et al., 1998; Nadler et al., 2000). They are increased during 
inflammation, and the expression levels are positively correlated with the severity of 
inflammatory responses (Gao et al., 2016; Lin et al., 2016). IL-2, IL-10, and TGF-β1 
are three of the most important anti-inflammatory cytokines in the human immune 
response (Miller et al., 2002a, b; Curtis and Pavletic, 2016; Guo et al., 2016; Zhou et 
al., 2016). Our data indicated that the serum levels of TNF-α, IL-6, IL-2, IL-10, and 
TGF-β1 were higher in the CPID model group than those in the control group. After 
treatment with MPF, the serum levels of these inflammatory cytokines decreased 
significantly and were similar to those in the control group, suggesting that MPF 
might play a positive role in the anti-inflammatory process by downregulating the 
serum levels of inflammatory cytokines to recover the balance of immune system. 
Jingangteng capsules were chosen as a positive control for medicine treated CPID in 
rats. Jingangteng is the root of Smilax china L., which has anti-inflammatory effects 
and improves blood circulation (Khan et al., 2009; Luo et al., 2014). We observed that 
MPF had similar anti-inflammatory effects to Jingganteng capsules on CPID in rats, 
and the high-dose MPF was in fact more effective than Jingganteng capsules. 
Apoptosis or programmed cell death (PCD) is considered a vital component of various 
processes including normal cell turnover, proper development and functioning of the 
immune system, hormone-dependent atrophy, embryonic development and 
chemical-induced cell death (Elmore, 2007). Inappropriate apoptosis (either too little 
or too much) is a factor in many human conditions including neurodegenerative 
diseases, ischemic damage, autoimmune disorders and many types of cancer. In recent 
years, the relationship between apoptosis and chronic inflammatory disease is 
receiving more and more attention. There is evidence to show that the blocking of 
inflammatory cells’ apoptosis may be one of the pathogenesis of chronic 
inflammation (Pacova et al., 2009). Triggering the apoptosis of inflammatory cells is 
one of the mechanisms of improving the chronic inflammation. The results of 
quantitative RT-PCR showed that the expressions of P53 mRNA, Fas/FasL mRNA, 
and MMP-2 mRNA in uterus were significantly elevated after treatment with MPF 
and the expression of TGF-β1 mRNA was reduced. The expression of P53 mRNA, 
Fas/FasL mRNA, and MMP-2 mRNA all have an effect to promote the apoptosis 
(Kitamura et al., 2001; Dmitrieva et al., 2003; Smane et al., 2013; Zhang et al., 2015; 
Umezawa et al., 2016). High expression of TGF-β1 mRNA can induce the activation 
of anti-apoptotic cytokine NF-κb, resulting in blocking of inflammatory cells’ 
apoptosis. The immunohistochemistry analysis showed that the expressions of NF-κB 
p65 in uterus and ovary tissues were inhibited after treatment with MPF. The results 
indicate that MPF may reduce the inflammatory reaction and eliminate the chronic 
pelvic inflammation by promoting and inducing the apoptosis of inflammatory cells.   
 
5. Conclusions 
MPF has noteworthy anti-inflammatory effect on CPID, and this effect is dose – 
dependent. It may play a positive role in the anti-inflammatory process by 
downregulating the serum levels of inflammatory cytokines and at the same time it 
may reduce the inflammatory reaction and eliminate CPID by promoting and inducing 
the apoptosis of inflammatory cells. Our results indicate that MPF may have a role in 
the medical treatment of CPID. 
 
Conﬂict of interest 
None. 
 
Acknowledgments 
This work was supported by Traditional Chinese Medicine Development Special 
Funds ‘standardized clinical validation of hospital preparation and experience 
prescription’ of Shanghai Pudong new area (PDYNZJ2015-02), the Outstanding 
Leaders Training Program of Pudong Health Bureau of Shanghai (PWR12015-05), 
the State Key Laboratory Breeding Base of Systematic Research, Development and 
Utilization of Chinese Medicine Resources (ME2016012) and the Talents Training 
Program of Seventh People’s Hospital of Shanghai University of TCM (XX2017-01). 
 
Li-Jun Zhang (E-mail: zhanglijun0407@163.com), who is contribute to the operation 
of molecular biology experiments and the writing of this manuscript. Jian-Yong Zhu 
(E-mail: jyzhu@foxmail.com), who is contribute to the identification of compounds 
in the Chinese herbal compound by high-performance liquid chromatography coupled 
with electrospray mass spectrometry (HPLC/ESI-MS). Meng-Yao Sun (E-mail: 
1461293225@qq.com), Ya-Nan Song (E-mail: synabc.123@163.com) and Miao 
Zhang (E-mail: zhangmiao1083@163.com), who are contribute to the operation of 
molecular biology experiments and collecting the experimental data. Khalid Rahman 
(E-mail: K.Rahman@ljmu.ac.uk) and Cheng Peng (E-mail: Davor_1234@126.com), 
who are contribute to the language modification of this manuscript. Hong Zhang 
(E-mail addresses: hqzhang51@126.com) and Yu-Mei Ye (E-mail addresses: 
yeyumei0206@163.com), who are contribute to the design of the whole experiments 
and modification of this manuscript. 
References 
Alexander, R.B., Ponniah, S., Hasday, J., Hebel, J.R., 1998. Elevated levels of 
proinflammatory cytokines in the semen of patients with chronic 
prostatitis/chronic pelvic pain syndrome. Urology 52, 744-749. 
Barrett, S., Taylor, C., 2005. A review on pelvic inflammatory disease. Int. J. Std & 
Aids 16, 715-720. 
Basic Kes, V., Simundic, A.M., Nikolac, N., Topic, E., Demarin, V., 2008. 
Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and 
their relation to early neurological deficit and stroke outcome. Clin. Biochem. 41, 
1330-1334. 
Bu, X.L., Liu, Y.X., Lu, Q.D., Jin, Z., 2015. Effects of "Danzhi Decoction" on 
Chronic Pelvic Pain, Hemodynamics, and Proinflammatory Factors in the 
Murine Model of Sequelae of Pelvic Inflammatory Disease. Evid-Based Compl 
Alt. 2015, 1-12. 
Burnakis, T.G., Hildebrandt, N.B., 1986. Pelvic inflammatory disease: a review with 
emphasis on antimicrobial therapy. Rev. Infect. Dis. 8, 86-116. 
Cassell, J., Kell, P., Adler, M., 1997. Pelvic inflammatory disease: a review. J. Int. 
Assoc. Physic. in Aids Care 3, 20-23. 
Chen, K.J., 2012. Blood stasis syndrome and its treatment with activating blood 
circulation to remove blood stasis therapy. Chin. J. Integr. Med. 18, 891-896. 
Chen, L.Y, Yin, H.F., Lan, Z., Ma, S.W., Zhang, C.F., Yang, Z.L., Li, P., Lin, B.Q., 
2011. Anti-hyperuricemic and nephroprotective effects of Smilax china L. J. 
Ethnopharmacol. 135, 399-405. 
Chen, Y., Tian, L., Wang, X., Wang, C.X., 2008. Drug Particles of FUYANNING to 
Cheonic Pelvic Inflammatory Disease Model of the Impact of Rats IL-2, IL-6. 
Chin. Arch. Traditional Chin. Med. 26(8). 
Chou, C.W., Lin, F.C., Tsai, H.C., Chang, S.C., 2013. The importance of 
pro-inflammatory and anti-inflammatory cytokines in Pneumocystis jirovecii 
pneumonia. Medical Mycol. 51, 704-712. 
Christensen, V.B., Toft, P., Tonnesen, E.K., 1998. Inflammatory response of the body 
to surgery illustrated by pro-inflammatory and anti-inflammatory cytokines. 
Ugeskrift for Laeger 160, 6951-6953. 
Curtis, L.M., Pavletic, S.Z., 2016. IL-2, the next best thing in chronic GVHD therapy? 
Blood 128, 13-15. 
Dinarello, C.A., 1997. Role of pro- and anti-inflammatory cytokines during 
inflammation: experimental and clinical findings. J. Biol. Regul Homeost Agents 
11, 91-103. 
Dmitrieva, E.V., Moskaleva, E., Kogan, E.A., Bueverov, A.O., Belushkina, N.N., 
Ivashkin, V.T., Severin, E.S., Pal'tsev, M.A., 2003. The role of Fas/FasL system 
in induction of hepatocyte apoptosis in chronic viral hepatitides. Arkh Patol 65, 
13-17. 
Duarte, R., Fuhrich, D., Ross, J.D., 2015. A review of antibiotic therapy for pelvic 
inflammatory disease. Int. J. Antimicrob. Agents 46, 272-277. 
Elmore, S., 2007. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35, 
495-516. 
Gao, X., Li, Y., Wang, H., Li, C., Ding, J., 2016. Inhibition of HIF-1alpha decreases 
expression of pro-inflammatory IL-6 and TNF-alpha in diabetic retinopathy. 
Acta Ophthalmol. 
Gradison, M., 2012. Pelvic inflammatory disease. Am. Fam. Physician 85, 791-796. 
Guo, W., Liu, Z.Y., Wei, Z.L., Lou, M.Q., Zhan, Q.B., Zhao, Y.D., 2016. TGF-beta1 
polymorphism in glioma. J. Neurosurg. Sci. 60, 401-402. 
Haggerty, C.L., Peipert, J.F., Weitzen, S., Hendrix, S.L., Holley, R.L., Nelson, D.B., 
Randall, H., Soper, D.E., Wiesenfeld, H.C., Ness, R.B., 2005. Predictors of 
chronic pelvic pain in an urban population of women with symptoms and signs 
of pelvic inflammatory disease. Sex. Transm. Dis. 32, 293-299. 
Khan, I., Nisar, M., Ebad, F., Nadeem, S., Saeed, M., Khan, H., Samiullah, Khuda, F., 
Karim, N., Ahmad, Z., 2009. Anti-inflammatory activities of Sieboldogenin from 
Smilax china Linn.: experimental and computational studies. J. Ethnopharmacol. 
121, 175-177. 
Kim, Y., Koh, J.H., Ahn, Y.J., Oh, S., Kim, S.H., 2015. The Synergic 
Anti-inflammatory Impact of Gleditsia sinensis Lam. and Lactobacillus brevis 
KY21 on Intestinal Epithelial Cells in a DSS-induced Colitis Model. Korean J. 
Food Sci.Anim. Resour. 35, 604-610. 
Kitamura, Y., Hashimoto, S., Mizuta, N., Kobayashi, A., Kooguchi, K., Fujiwara, I., 
Nakajima, H., 2001. Fas/FasL-dependent apoptosis of alveolar cells after 
lipopolysaccharide-induced lung injury in mice. Am. J. Respir. Crit. Care Med. 
163, 762-769. 
Lee, S.E., Ju, E.M., Kim, J.H., 2001. Free radical scavenging and antioxidant enzyme 
fortifying activities of extracts from Smilax china root. Exp. Mol. Med. 33, 
263-268. 
Li, K.K., Zhou, X., Wong, H.L., Ng, C.F., Fu, W.M., Leung, P.C., Peng, G., Ko, C.H., 
2016. In vivo and in vitro anti-inflammatory effects of Zao-Jiao-Ci (the spine of 
Gleditsia sinensis Lam.) aqueous extract and its mechanisms of action. J. 
Ethnopharmacol. 192, 192-200. 
Li, W.H., Zhang, X.M., Tian, R.R., Zheng, Y.T., Zhao, W.M., Qiu, M.H., 2007. A 
new anti-HIV lupane acid from Gleditsia sinensis Lam. J. Asian. Nat. Prod. Res. 
9, 551-555. 
Lin, C.C., Li, T.C., Liu, C.S., Yang, C.W., Lin, C.H., Hsiao, J.H., Meng, N.H., Lin, 
W.Y., Liao, L.N., Li, C.I., Wu, F.Y., 2016. Associations of TNF-alpha and IL-6 
polymorphisms with osteoporosis through joint effects and interactions with 
LEPR gene in Taiwan: Taichung Community Health Study for Elders (TCHS-E). 
Mol. Biol. Rep.43:1-13. 
Liu, B.Q., Gong, X., Jin, Z., 2014. Effect of Danzhi decoction on expression of 
angiogenesis factors in patients with sequelae of pelvic inflammatory disease. 
Asian Pac. J. Trop. Med. 7, 985-990. 
Loucks, A., 1983. Pelvic inflammatory disease: a review of therapy. The Nurse Pract. 
8, 13-19, 23. 
Luo, Y., Ma, Y., Song, L., Luo, H., Hou, L., 2014. Effect of Smilax china bioactive 
fraction on tumor necrosis factor-alpha and interleukin-4 contents in uterine 
tissue of rats with chronic pelvic inflammatory disease. J. South. Med. Univ. 34, 
236-240. 
Miller, L.J., Fischer, K.A., Goralnick, S.J., Litt, M., Burleson, J.A., Albertsen, P., 
Kreutzer, D.L., 2002a. Interleukin-10 levels in seminal plasma: implications for 
chronic prostatitis-chronic pelvic pain syndrome. J. Urol. 167, 753-756. 
Miller, L.J., Fischer, K.A., Goralnick, S.J., Litt, M., Burleson, J.A., Albertsen, P., 
Kreutzer, D.L., 2002b. Nerve growth factor and chronic prostatitis/chronic pelvic 
pain syndrome. Urology 59, 603-608. 
Mitchell, C., Prabhu, M., 2013. Pelvic inflammatory disease: current concepts in 
pathogenesis, diagnosis and treatment. Infect. Dis. Clin. North. Am. 27, 793-809. 
Nadler, R.B., Koch, A.E., Calhoun, E.A., Campbell, P.L., Pruden, D.L., Bennett, C.L., 
Yarnold, P.R., Schaeffer, A.J., 2000. IL-1beta and TNF-alpha in prostatic 
secretions are indicators in the evaluation of men with chronic prostatitis. J. Urol. 
164, 214-218. 
Pacova, H., Astl, J., Martinek, J., 2009. The pathogenesis of chronic inflammation and 
malignant transformation in the human upper airways: the role of beta-defensins, 
eNOS, cell proliferation and apoptosis. Histol. Histopathol. 24, 815-820. 
Park, S.H., Ko, S.K., Chung, S.H., 2005. Euonymus alatus prevents the 
hyperglycemia and hyperlipidemia induced by high-fat diet in ICR mice. J. 
Ethnopharmacol. 102, 326-335. 
Shah, C.S., Sukkawala, V.M., Chavan, A.R., 1962. Pharmacognostic study of Smilax 
china L. rhizome. J.Sci. Ind. Res. (C), 21C,19-21. 
Smane, L., Pilmane, M., Akota, I., 2013. Apoptosis and MMP-2, TIMP-2 expression 
in cleft lip and palate. Stomatologija 15, 129-134. 
Snaith, L., 1959. Chronic pelvic inflammation and infertility. Clin Obstet Gynecol. 2, 
862-876. 
Tuffrey, M., Alexander, F., Woods, C., Taylor-Robinson, D., 1992. Genetic 
susceptibility to chlamydial salpingitis and subsequent infertility in mice. J 
Reprod Fertil 95, 31-38. 
Umezawa, Y., Kurosu, T., Akiyama, H., Wu, N., Nogami, A., Nagao, T., Miura, O., 
2016. Down regulation of Chk1 by p53 plays a role in synergistic induction of 
apoptosis by chemotherapeutics and inhibitors for Jak2 or BCR/ABL in 
hematopoietic cells. Oncotarget 7, 44448-44461. 
Wang, L., Cui, D.G., Wang J.Z., Zhang, J.Y., Yang, Z.Q,, Qin, Z. Kong, X.J., Wang, 
X.Z., Li, J.X., 2015. Analgesic and anti-inflammatory effects of hydroalcoholic 
extract isolated from Semen vaccariae. Pak J Pharm Sci 28, 1043-1048. 
Ye, Y.M., Yang W., Zhang, X.D., Wu, W.W., Cai, Y., 2012. Clinical observation of 
Man-Pen-Fang for the treatment of pelvic inflammatory disease, Proceedings of  
International conference on gynecology of TCM, 220-222. 
Ye, Y.M., Zhang, L.J., Xiao, L., Dai, J.J., 2016. Experimental study on 
anti-inflammatory and analgesic effect of ManPenFang. Shanghai Journal of 
TCM 50, 92-95. 
Zhang, J.X., Han, Y.P., Bai, C., Li, Q., 2015. Notch1/3 and p53/p21 are a potential 
therapeutic target for APS-induced apoptosis in non-small cell lung carcinoma 
cell lines. Int J Clin Exp Med 8, 12539-12547. 
Zhou, L.G., Li, D., Wang, J.G., Liu, Y.S., Wu, J.Y., 2007. Antibacterial phenolic 
compounds from the spines of Gleditsia sinensis Lam. Nat Prod Res 21, 
283-291. 
Zhou, X., Hopkins, J.W., Wang, C.K., Brahmakshatriya, V., Swain, S.L., Kuchel, 
G.A., Haynes, L., McElhaney, J.E., 2016. IL-2 and IL-6 cooperate to enhance the 
generation of influenza-specific CD8 T cells responding to live influenza virus in 
aged mice and humans. Oncotarget 7, 39171-39183. 
 
 
